BioNTech stock falls after cancer trial misses key endpoint

Here’s why Goldman Sachs upgraded Technip Energies’ stock rating

Investing.com · News 7m ago

Albertsons beats Q2 earnings but withdraws fiscal 2026 outlook

Investing.com · Investing_news 10m ago

Albertsons beats Q2 earnings but withdraws fiscal 2026 outlook

Investing.com · News 10m ago

European automakers seek policy support amid China pressure

Investing.com · Investing_news 10m ago

Caspian Therapeutics outlines development plan for diabetes drug

Investing.com · News 10m ago

European automakers seek policy support amid China pressure

Investing.com · News 10m ago

Seabridge Gold acquires Wyoming project for $300,000

Investing.com · News 10m ago

Select Water Solutions plans $800 million senior notes offering

Investing.com · News 10m ago

BrainsWay expands U.S. insurance coverage to 70 million lives

Investing.com · News 10m ago

Greggs stock downgraded by UBS. Here is why?

Investing.com · News 11m ago